|
|
STANDBY In-Person Registration for Industry Professionals | Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast CancerThank you for your interest. At this time registration to attend this activity in person is closed to industry professionals and nonclinicians. Please provide your name and email address below if you would like to be notified should seats become available, and we will be happy to alert you. If you have any questions or concerns, please contact us at Meetings@ResearchToPractice.com. If you would like to attend virtually, please register via our Zoom page here.
|